Details of the Drug Reposition

General Information of This Drug (ID: DM8JQZC)

Drug Name
BNZ-1   DM8JQZC
Drug Type
Peptide

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
T-cell leukaemia DISJ6YIF 2A90 Phase 2 [1]
Cutaneous T-cell lymphoma DISAYSZB 2B01 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)